Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Positive pivotal phase III data for Epolong in CKD

Dec. 11, 2020

Galapagos begins phase II trial of CFTR inhibitor GLPG-2737 for ADPKD

Dec. 3, 2020

Allena presents initial phase I data on ALLN-346 for hyperuricemia

Dec. 1, 2020

Experimental aorta transplantation ameliorates uremic vascular calcification in rats

Nov. 12, 2020

EZH2 as novel therapeutic target for chronic kidney disease

Nov. 12, 2020

Janssen Pharmaceutica discloses BARK1 inhibitors

Nov. 11, 2020

Phase III CARDINAL study of bardoxolone in Alport syndrome meets primary endpoint

Nov. 10, 2020

Phase III trial of Nefecon in primary IgAN meets key endpoints

Nov. 9, 2020

CaMK4 as potential target to slow cyst growth in PKD

Nov. 9, 2020

SYNB-8802 consumes GI oxalate in animals with acute hyperoxaluria

Nov. 6, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...